SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 68,210 shares of the exchange traded fund’s stock after selling 5,259 shares during the quarter. Tocqueville Asset Management L.P. owned approximately 0.09% of SPDR S&P Biotech ETF worth $6,143,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Golden State Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $29,000. Kohmann Bosshard Financial Services LLC acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $29,000. Avior Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after acquiring an additional 307 shares during the period. Bank of Jackson Hole Trust acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $43,000. Finally, Addison Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 27.4% during the 4th quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock worth $48,000 after purchasing an additional 115 shares during the period.

SPDR S&P Biotech ETF Stock Down 2.4 %

Shares of NYSEARCA:XBI opened at $86.17 on Wednesday. The company has a market cap of $5.59 billion, a P/E ratio of 11.47 and a beta of 0.99. The business has a fifty day simple moving average of $89.85 and a 200-day simple moving average of $94.58. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.